New Drug Approvals

<< Drug Pipeline Review

Last updated: 05.10.22

Date Drug Manufacturer Use Specialty
3/14/22 Adlarity (donepezil patch) Corium Alzheimer's Disease  
3/17/22 Nasonex 24HR Allergy (OTC) Perrigo Allergic Rhinitis  
3/18/22 Ztalmy (ganaxolone) Marinus CDKL5 deficiency disorder S
3/18/22 Opdualag (nivolumab andrelatlimab‐rmbw) Bristol Myers Squibb Melanoma S
3/22/22 Hyftor (sirolimus topical gel) Nobelpharma Tuberous Sclerosis Comples  
3/23/22 Xelstrym (dextroamphetamine transdermal system) Noven ADHD  
3/23/22 Locametz (gallium Ga 68 gozetotide) Novartis Prostate Cancer S
3/23/22 Pluvicto (lutetium Lu 177 vipivotide tetraxetan) Novartis Prostate Cancer S
3/29/22 Tlando (testosterone undecanoate) Lipocine Hypogonadism  
3/30/22 Triumeq (abacavir/ dolutegravir/lamivudine) ViiV Healthcare HIV S
4/5/22 Vijoice (alpelisib) Novartis PIK3CA‐related overgrowth spectrum S
4/5/22 Igalmi (dexmedetomidine SL) BioXcel Agitation  
4/14/22 Alymsys (bevacizumab‐maly) Amneal Cancer S

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, review your plan documents or contact a Cigna representative.

All Cigna products and service are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Evernorth Care Solutions, Inc., Evernorth Behavioral Health, Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.

© 2024 Cigna. All rights reserved